An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
Clinical trial NCT01323192 · COMPLETED
Trial details
- NCT number
- NCT01323192
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-04-01
- Enrollment
- 284
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.